| Literature DB >> 19857966 |
Stephanos Ioannidis1, Michelle L Lamb, Audrey M Davies, Lynsie Almeida, Mei Su, Geraldine Bebernitz, Minwei Ye, Kirsten Bell, Marat Alimzhanov, Michael Zinda.
Abstract
The design, synthesis and biological evaluation of a series of pyrazol-3-ylamino pyrazines as potent and selective JAK2 kinase inhibitors is reported, along with the pharmacokinetic and pharmacodynamic properties of lead compounds.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19857966 DOI： 10.1016/j.bmcl.2009.10.054
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN： 0960-894X Impact factor: 2.823